Sandesh Seth - Dec 28, 2023 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Role
Chief Executive Officer, Director
Signature
/s/ Sandesh Seth
Stock symbol
ATNM
Transactions as of
Dec 28, 2023
Transactions value $
$0
Form type
4
Date filed
12/29/2023, 05:17 PM
Previous filing
Aug 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNM Stock Option (Right to Buy) Award $0 +984K $0.00 984K Dec 28, 2023 Common Stock 984K $5.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant.
F2 Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested.